MEDICAL MARIJUANA FORCING HURRY UP OF CANNABOID DRUGS IN USA

26 ביוני 2014

ALTHOUGH PHENOMENAL STUDIES IN UK FROM THEIR PARENT PLC THEY HAVE FINALIZED A SECONDARY THAT HAS LED TO AN INCREASE IN PRICE WHICH IS RARE. IT WAS OVER SUBSCRIBED AND IT WENT QUICK. GWPH IS STUCK IN CHANNEL ON UPTREND AND WILL CONTINUE TO RISE POSSIBLE RESISTANCE IS IT'S 8 APX 88.64 EMA AND 10 APX 87.16 EMA HOWEVER IT HAS SHOWN STRENGTH THROUGH THIS DILUTION AND CONTINUED ITS TREND WITHOUT MINIMAL SIGNS OF WEAKNESS. IT TRIED BREAKING THROUGH THE RESISTANCE OF THE 8 DAY HOWEVER IF BOUNCED BACK UP TO THE CLOSE. TOO MUCH NEW TERRITORY FOR A NEGATIVE SELL JUNCTURE AND TOO MANY USES FOR THEIR DRUGS WHICH ARE LEADING TO TIMELIER PROGRESSION OF THE US BASED CANNABOID PRODUCTS AND EVEN A FLURRY INTO PRICE GROWTH IN SPEC COMPANIES WITHOUT TRACK RECORDS.